Published by ChinaMNC · Luotian
China’s Antitrust Watchdog Holds Compliance Workshop for Tech and Pharma Firms in Shanghai
On October 29, China’s State Administration for Market Regulation (SAMR) held its fifth antitrust compliance workshop of 2026 in Shanghai, targeting AI, quantum tech, and pharmaceutical companies. The session aimed to help businesses identify and prevent monopolistic risks, with over 100 companies and industry associations participating. For foreign founders in China, this signals heightened scrutiny and the need for robust compliance programs.
China’s Antitrust Regulator Targets Tech and Pharma with Compliance Workshop
On October 29, the State Administration for Market Regulation (SAMR) convened its fifth antitrust compliance workshop of 2026 in Shanghai. The event, themed “Strengthening Antitrust Compliance to Empower the Construction of the Shanghai (Yangtze River Delta) International Science and Technology Innovation Center,” was aimed at technology-driven enterprises—including those in artificial intelligence and quantum technology—as well as companies in active pharmaceutical ingredients and innovative drugs. The workshop sought to guide businesses in scientifically identifying, accurately assessing, and effectively preventing monopolistic risks, and to encourage lawful competition and compliant operations. The ultimate goal is to foster a fair competitive market environment that supports the development of an international hub for science and technology innovation.
Key Messages from SAMR
SAMR emphasized the need to thoroughly implement the decisions and arrangements of the Party Central Committee and the State Council, to fully leverage the role of antitrust enforcement in protecting fair competition and stimulating innovation, to remove bottlenecks in the flow of production factors, and to strive to create a fair, transparent, stable, and predictable market environment. The administration urged all types of businesses to shoulder their primary responsibility for antitrust compliance, to strengthen internal compliance management systems, to integrate compliance requirements throughout the entire production and operation chain, and to proactively guard against various monopolistic risks.
Who Participated
The workshop was attended by relevant departments including SAMR’s First Antitrust Enforcement Division, the Shanghai Municipal Administration for Market Regulation, the Jiangsu Provincial Administration for Market Regulation, the Zhejiang Provincial Administration for Market Regulation, and the Anhui Provincial Administration for Market Regulation. Also present were SAMR’s Competition Policy Center and more than 100 businesses and industry associations, participating both online and offline.
Implications for Foreign Founders in China
For foreign founders registering or operating a company in China, this workshop underscores the increasing regulatory focus on antitrust compliance, particularly in high-growth sectors such as AI, quantum technology, and pharmaceuticals. While the workshop itself is educational, it signals that Chinese authorities are actively engaging with companies to prevent anticompetitive behavior. Foreign founders should take note of the following practical points:
- Compliance is a shared responsibility: SAMR stresses that companies must take primary responsibility for their antitrust compliance. This means foreign-invested enterprises should establish and maintain robust internal compliance programs.
- Sector-specific scrutiny: The workshop specifically targeted AI, quantum tech, and pharmaceutical companies, indicating that these sectors may receive heightened attention from regulators.
- Market environment goals: The push for a fair, transparent, and predictable market environment is part of broader efforts to attract innovation and investment. Compliance can help foreign founders build trust and avoid disruptions.
- Engagement opportunities: Events like this demonstrate that Chinese regulators are open to dialogue with businesses. Foreign founders can seek similar engagement to better understand local expectations.
What This Means for Your China Strategy
If you are planning to register a company in China or are already operating there, it is advisable to review your antitrust compliance policies, especially if your business falls within the targeted sectors. While the workshop did not announce new enforcement actions, it reinforces the importance of aligning with Chinese competition law. Foreign founders should consider conducting internal audits, training staff on compliance, and staying informed about regulatory developments.
For assistance with company registration, compliance, and operations in China, foreign founders can reach out to ChinaMNC via WhatsApp or WeChat at +86 153 1898 8535.
This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.